Literature DB >> 24160815

The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.

Florian Krammer1, Rebecca J Cox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24160815     DOI： 10.1586/14760584.2013.850036

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  16 in total

1.  Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Authors:  Nancy J Cox; Julian Hickling; Rebecca Jones; Guus F Rimmelzwaan; Linda C Lambert; John Boslego; Larisa Rudenko; Leena Yeolekar; James S Robertson; Joachim Hombach; Justin R Ortiz
Journal:  Vaccine       Date:  2015-10-23       Impact factor: 3.641

2.  Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Katherine Richards; Frances Batarse; Laura Lockard; Hui Zeng; Adolfo García-Sastre; Randy A Albrecht; Andrea J Sant
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

Review 3.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

4.  Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.

Authors:  Wentao Shen; Qian Wang; Zhengxiang Wang; Minxuan Liu; Yingying Du; Lvfeng Yuan; Lu Han; Krzysztof Smietanka; Hualan Chen; Shuai Xu; Qiyun Zhu
Journal:  J Virol       Date:  2022-08-29       Impact factor: 6.549

5.  Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.

Authors:  Li Wang; Timothy Z Chang; Yuan He; Jong R Kim; Shelly Wang; Teena Mohan; Zachary Berman; S Mark Tompkins; Ralph A Tripp; Richard W Compans; Julie A Champion; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2016-09-10       Impact factor: 5.307

Review 6.  Mammalian models for the study of H7 virus pathogenesis and transmission.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

7.  The value of HIV protective epitope research for informed vaccine design against diverse viral pathogens.

Authors:  Victor G Kramer; Siddappa N Byrareddy
Journal:  Expert Rev Vaccines       Date:  2014-06-26       Impact factor: 5.217

8.  An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.

Authors:  Florian Krammer; Asne Jul-Larsen; Irina Margine; Ariana Hirsh; Haakon Sjursen; Maria Zambon; Rebecca J Cox
Journal:  Clin Vaccine Immunol       Date:  2014-06-18

9.  Divergent H7 immunogens offer protection from H7N9 virus challenge.

Authors:  Florian Krammer; Randy A Albrecht; Gene S Tan; Irina Margine; Rong Hai; Mirco Schmolke; Jonathan Runstadler; Sarah F Andrews; Patrick C Wilson; Rebecca J Cox; John J Treanor; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 10.  Evolutionary dynamics of highly pathogenic avian influenza A/H5N1 HA clades and vaccine implementation in Vietnam.

Authors:  Thanh Hoa Le; Nga Thi Bich Nguyen
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.